摘要
一方面是医院对体外诊断试剂的需求得不到满足,另一方面是体外诊断试剂产品很少能达到行业标准。
Steeping into the new century, some state departments begin to streamline the invitro-diagnostic reagent. Many corporations are small-scaled and non-standard in terms of marketing management in this industry. To further promote the production, distribution and usage of invitro-diagnostic reagent, SFDA unveils a set of rules and regulations. This industry is expected to embark on a healthy and orderly road of development. In the standard and orderly environment, the corporations will get the full chance to grow up and produce national brand capable of challenging international competition.
出处
《中国医院院长》
2007年第12期58-62,共5页
China Hospital CEO